Cargando…
Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations
Fructosamine-3-kinase (FN3K) is involved in the deglycation of Nrf2, a significant regulator of oxidative stress in cancer cells. However, the intricate functional aspects of FN3K and Nrf2 in breast cancers have not been explored vividly. The objectives of this study are to design the human FN3K pro...
Autores principales: | Beeraka, Narasimha M., Zhang, Jin, Mandal, Subhankar, Vikram P. R., Hemanth, Liu, Junqi, B. M., Namitha, Zhao, Di, Vishwanath, Prashanth, B. M., Gurupadayya, Fan, Ruitai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619859/ https://www.ncbi.nlm.nih.gov/pubmed/37910519 http://dx.doi.org/10.1371/journal.pone.0283705 |
Ejemplares similares
-
The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
por: Beeraka, Narasimha M., et al.
Publicado: (2021) -
Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR)
por: Beeraka, Narasimha M, et al.
Publicado: (2022) -
Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase
por: De Decker, Ignace, et al.
Publicado: (2023) -
Structure of unliganded membrane-proximal domains FN4-FN5-FN6 of DCC
por: Finci, Lorenzo I., et al.
Publicado: (2017) -
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease
por: Alderawi, Amr, et al.
Publicado: (2020)